Clinical trial
Role of the Cardioflux Magnetocardiography System in Predicting Patient Outcomes With Coronary Artery Disease
NCT03968809 is registered in ClinicalTrials.gov with Genetesis Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of the Cardioflux Magnetocardiography System in Predicting Patient Outcomes With Coronary Artery Disease
- Lead sponsor
- Genetesis Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 5, 2019
- Completion date
- June 20, 2020
- Enrollment
- 101 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.